Cleared Abbreviated

K091952 - ACTA VESSEL OCCLUSION SYSTEM (VOS)

K091952 is an FDA 510(k) clearance for ACTA VESSEL OCCLUSION SYSTEM (VOS), manufactured by Nfocus Neuromedical, Inc.. The device is a Class 2 Cardiovascular device with product code KRD cleared through the Abbreviated 510(k) pathway after a 436-day FDA review.

K091952 · Nfocus Neuromedical, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Sep 2010
Decision
436d
Days
Class 2
Risk

K091952 is an FDA 510(k) clearance for the ACTA VESSEL OCCLUSION SYSTEM (VOS). Classified as Device, Vascular, For Promoting Embolization (product code KRD), Class II - Special Controls.

Submitted by Nfocus Neuromedical, Inc. (Palo Alto, US). The FDA issued a Cleared decision on September 10, 2010 after a review of 436 days - an unusually long review period, suggesting complex equivalence evaluation.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.3300 - the FDA cardiovascular device oversight framework. The Abbreviated 510(k) pathway was used, relying on FDA-recognized standards to demonstrate substantial equivalence.

Device pattern: High-complexity regulatory submission. Standards-verified equivalence. The extended review timeline suggests the FDA required additional documentation before confirming substantial equivalence - a pattern common in complex or first-of-kind Cardiovascular submissions.

View all Nfocus Neuromedical, Inc. devices

FDA 510(k) Submission Details - K091952

510(k) Number K091952 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received July 01, 2009
Decision Date September 10, 2010
Days to Decision 436 days
Submission Type Abbreviated
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
311d slower than avg
Panel avg: 125d · This submission: 436d
Pathway characteristics
Standards-based clearance path.

KRD Device Classification - Class 2, Special Controls

Product Code KRD Device, Vascular, For Promoting Embolization
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.3300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - KRD Device, Vascular, For Promoting Embolization

All 100
Devices cleared under the same product code (KRD) and FDA review panel - the closest regulatory comparables to K091952.
INTERLOCK-35 FIBERED IDC OCCLUSION SYSTEM
K110295 · Boston Scientific Corp · Mar 2011
COMPLEX HELICAL 18, MULTI-LOOP 18, FIGURE 8-18, STRAIGHT 18 FIBERED PLATINUM COILS, VORTX -18, VORTX 35 & 2D HELICAL
K102714 · Boston Scientific Corp · Feb 2011
MICROPLEX COIL SYSTEM- COSMOS
K102365 · MicroVention, Inc. · Nov 2010
AZUR PERIPHERAL HYDROCOIL ENDOVASCULAR EMBOLIZATION SYSTEM-DETACHABLE 35, MODELS 45-450405, 45-450410, 45-450610
K093002 · MicroVention, Inc. · Oct 2009
AZUR PERIPHERAL HYDROCOIL ENDOVASCULAR EMBOLIZATION SYSTEM
K091882 · MicroVention, Inc. · Jul 2009
COOK MREYE EMBOLIZATION COILS
K090624 · Cook, Inc. · Apr 2009